General practitioners' conceptions about treatment of depression and factors that may influence their practice in this area. A postal survey by Stig J Andersson et al.
BioMed CentralBMC Family Practice
ssOpen AcceResearch article
General practitioners' conceptions about treatment of depression 
and factors that may influence their practice in this area. A postal 
survey
Stig J Andersson*†1,2,3, Margareta Troein†1 and Gunnar Lindberg†2
Address: 1Lund University, Department of clinical Sciences Malmö, Family Medicine, MAS, S-20502 Malmö, Sweden, 2The NEPI Foundation, 
Malmö, Sweden and 3The Research department of primary care, County Council of Värmland, Karlstad, Sweden
Email: Stig J Andersson* - gits.joel@tele2.se; Margareta Troein - margareta.troein@med.lu.se; Gunnar Lindberg - gunnar.lindberg@nepi.net
* Corresponding author    †Equal contributors
Abstract
Background: The way GPs work does not appear to be adapted to the needs of depressive
patients. Therefore we wanted to examine Swedish GPs' conceptions of depressive disorders and
their treatment and GPs' ideas of factors that may influence their manner of work with depressive
patients.
Methods: A postal questionnaire to a stratified sample of 617 Swedish GPs.
Results: Most respondents assumed antidepressive drugs effective and did not assume that
psychotherapy can replace drugs in depression treatment though many of them looked at
psychotherapy as an essential complement. Nearly all respondents thought that clinical experiences
had great importance in decision situations, but patients' own preferences and official clinical
guidelines were also regarded as essential. As influences on their work, almost all surveyed GPs
regarded experiences from general practice very important, and a majority also emphasised
experiences from private life. Courses arranged by pharmaceutical companies were seen as
essential sources of knowledge. A majority thought that psychiatrists did not provide sufficient help,
while most respondents perceived they were well backed up by colleagues.
Conclusion: GPs tend to emphasize experiences, both from clinical work and private life, and
overlook influences of collegial dealings and ongoing CME as well as the effects of the
pharmaceutical companies' marketing activities. Many GPs appear to need more evidence based
knowledge about depressive disorders. Interventions to improve depression management have to
be supporting and interactive, and should be combined with organisational reforms to improve co-
operation with psychiatrists.
Background
Mood disturbances are widespread in western societies
and general practitioners (GPs) see many patients with
depressive disorders[1,2]. Only a minority of these
patients consult directly for psychological problems. More
often they consult their doctors because of bodily symp-
toms[3]. In addition, depressive disorders often present
combined with anxiety states[4,5] and a large proportion
of the depressed patients in primary care also suffer from
concurrent somatic diseases[6]. Consequently, when GPs
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plicated cases. The ways GPs handle these patients have
been criticised because of deficient identification and
insufficient treatment of the depressive disorders [7-11].
In two previous studies we explored Swedish GPs' concep-
tions of depressive disorders and their ideas on how their
working methods with depressed patients had been
shaped. We found a considerable variation in their con-
ceptions about depression, but a relative consensus con-
cerning drug treatment of major depression. As regards
manner of working, many interviewed GPs considered
individual experiences from general practice and private
life as more influential than academic education and pro-
fessional literature[12,13].
When further examining the geographic variation of sales
levels of antidepressant agents (ADs) we found weak but
statistically significant associations with some of local
GPs' conceptions of factors that may have formed the way
they treat depressive patients[14]. Thus, high sales levels
correlated positively with a high evaluation of ADs' effec-
tiveness in depression and panic disorders and were
inversely correlated with the degree of appreciation of psy-
chotherapy-based treatments. High sales levels were also
associated with a high evaluation of GPs' own clinical and
private experience, with a positive appreciation of the
work with depressed patients and with a high level of par-
ticipation in the pharmaceutical companies' activities.
The purpose of the present study was to elaborate further
the frequencies of Swedish GPs' conceptions of depressive
disorders and its treatment and of their ideas of factors




The present study made use of the same data collection as
the previous study of the relations between GPs' concep-
tions of treatment of depression and local sales levels of
ADs[14]. For that purpose we had surveyed a stratified
sampling of GPs based on the population's purchases of
ADs in each GP's working area. Information on purchases
of ADs for the year 2000 in each Swedish municipality
was obtained from Apoteket AB (The National Corpora-
tion of Swedish Pharmacies). We selected three groups of
municipalities; those with the highest, the average, and
the lowest AD sales rates. For each sales group, municipal-
ities were included according to their sales figures until
the total number of GPs working in the municipalities of
the group approximated 200. In that way we selected 617
GPs working in a total of 60 municipalities. The respond-
ents of a pilot study were not included. The names and
addresses were received from Läkarmatrikeln 2001, a
national register of Swedish physicians.
Instrument
A postal questionnaire was designed based on the find-
ings in the interview study[12,13]. A five-point Likert scale
ranging from "Agree not at all" to "Agree completely" and
from "Very little importance" to "Very great importance"
was used for most items. The questionnaire was tested in
20 GPs. That pilot study had a response rate of 75 per cent,
no internal drop off, i.e. all responders answered all items,
and the answers were spread over the alternatives of the
Likert scale on most items. After a few modifications the
questionnaire was finalized[15].
In the graphs, the GP's answers are combined to a three-
point scale after merging alternatives 1 and 2 and alterna-
tives 4 and 5 of the original five-point Likert scale.
Performance
The survey was carried out in spring 2001. The question-
naires, including a return envelope, were mailed from the
NEPI Foundation, a non-profit organisation for studies on
epidemiology of drugs, to all the 617 GPs working in the
selected municipalities. No incentive for participation was
offered. Two reminders were sent if no answer was
received, the second of which included a new
questionnaire.
After the data collection, the work places of non-respond-
ents were contacted to ascertain whether or not these GPs
were still employed at the time of the survey.
The present analysis of data was not reported to the Ethics
Committee because our earlier studies had been approved
on the administrative level alone.
Results
After the second reminder 317 of the 617 mailed ques-
tionnaires were returned. Among non-respondents 82
had left their work places leaving 535 GPs eligible for the
survey. The response rate of the eligible participants was
59.4 percent: 56 percent among the 339 men and 65 per-
cent among the 196 women.
Among respondents, the average age was 48.7 years and
they had worked as GPs for 12.7 years on average. Sixty
percent were male. Among non-respondents available for
the survey, the average age was 59.0 years and 69 percent
were male.
To work with depressive patients was perceived a more
positive than negative task by 69 per cent of the respond-
ents, "neither positive, nor negative" by 27 per cent and
mainly negative by four per cent of the respondents.Page 2 of 9
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nearly all GPs considered that their own clinical experi-
ences of the treatment had great importance, and, for a
majority, also patients' own preferences and clinical
guidelines to treatment were of major value (Fig. 1).
Treatment of moderate depression includes mainly anti-
depressant medication and psychotherapy. A majority of
the respondents agreed that medication with ADs is effec-
tive, and did not assume that psychotherapy can replace
drug treatment. A majority agreed, fully or partially, that
psychotherapy is needed as a complement to drug treat-
ment (Fig. 2).
Most responders had great confidence in ADs for treat-
ment of panic disorder and thought they are effective also
in obsessive-compulsive disorders and social phobias
(Fig. 3), but the majority of the responders showed a lim-
ited reliance on ADs' effectiveness to treat sleep disorders,
psychosomatic illness, chronic pain, and premenstrual
syndrome.
Two thirds of the responding GPs considered ADs as effec-
tive for the treatment of old people as for people at
younger ages. Their confidence in psychotherapy for old
patients was low. The responders' judgments on the state-
ment that ADs are effective for the treatment of anxiety
and behavioural disturbances in patients with dementia
were distributed evenly from agree not at all to completely
agreement (Fig. 4).
Table 1 displays factors, which, according to the GPs, may
have influenced their manner of working with depressed
patients. Almost all regarded individual experiences from
family medicine as very important, and a large majority
also regarded experiences from private life to be of signif-
icant importance.
Some issues concerned continuing medical education
(CME). Much the same number of GPs considered non-
commercial courses to be of great importance as courses
arranged by pharmaceutical companies. The respondents
regularly took part in more lectures arranged by drug
Factors of importance for decision about antidepressive treatmentigure 1
Factors of importance for decision about antidepressive treatment. Mark which importance you attach to each of 
the mentioned factors when you decide about antidepressive treatment: a. The patient's own attitude towards different forms 
of treatment; b. Guidelines for treatment; c. Your previous clinical experience of the treatment.
0 20 40 60 80 100
The patients’ own attitude 
towards different forms of 
treatment
Guidelines for treatment (from
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mercial interests (Table 2). Commercial courses were gen-
erally regarded as meeting high standards. More than one
third of the respondents thought they had received more
knowledge from such courses than from commercially
independent education. A majority of the respondents
agreed partly or completely that commercially sponsored
courses may influence physicians in an inappropriate
way, but many GPs did not recognise that risk (Fig. 5).
Most respondents stated that they had good possibilities
to discuss with their colleague GPs. In contrast, a majority
claimed that psychiatrists do not provide them with the
necessary support for patient care.
Discussion
Our purpose was to investigate conceptions concerning
depressive disorders among Swedish GPs. We found that
GPs regarded experiences from family medicine and from
private life more important than university and post-grad-
uate education as influences on their work with depressive
patients. Most GPs had great confidence in ADs for treat-
ment of depressive disorders and panic disorder and
thought that the drugs are effective also in obsessive-com-
pulsive disorders and social phobias. A majority of GPs
also agree that commercially sponsored courses may
influence physicians in an inappropriate way, but many of
them do not recognise that risk.
Method considerations
For the purpose of an additional study utilizing the same
data collection, the sampling procedure was not ran-
domised but stratified. The participants were all GPs who
worked in the selected municipalities. They constituted
groups of GPs with different levels of prescribing ADs and
were from all parts of Sweden. We assume the procedure
resulted in an appropriate sample of Swedish GPs.
A response rate of 59 percent among eligible GPs is well
in line with comparable surveys among physicians,
although such a rate means that the possible impact of
selection bias must be considered [16-20]. However, there
are solid arguments that the result of the questionnaire
can be viewed as representative even if the response rate is
moderate, when a homogenous professional group is sur-
veyed on issues of central professional importance [22-
Psychotherapy and drug treatmentFigure 2
Psychotherapy and drug treatment. Give for each statement your degree of agreement: a. Psychotherapy is needed as a 
compliment to drug treatment in most cases. b. Drug treatment with antidepressive agents (ADs) may be replaced by psycho-
therapy, e.g. cognitive therapy, if the patient is prepared. c. Drug treatment with ADs is effective and sufficient in most cases.
0 20 40 60 80 100
Drug treatment with ADs
is effective and sufficient 
in most cases
Drug treatment with ADs may be replaced 
by psychotherapy, e.g. cognitive therapy,
if the patient is prepared
Psychotherapy is needed as a
complement to drug treatment
in most cases
Percent of respondents
Agree not at all
Agree partly
Agree completelyPage 4 of 9
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selected GPs even if there were minor differences in
gender distribution and age between responders and non-
responders.
The questionnaire was not validated against any earlier
instrument, but the items of the questionnaire were
extracted from findings of the previous interview studies
among GPs, a procedure that should ensure the relevance
of the items [12,13]. The questionnaire was tested by a
pilot study that had a response rate of 75 per cent and an
extensive spread of responses over the alternatives of the
Likert scales. In the present study there were a few internal
drop-offs, i.e. some responders did not answer all items.
Altogether, we claim that the present study has acceptable
representativeness and validity.
Interpretation of the findings
The respondents opinions of the usefulness of ADs in
treatment of moderate depression and anxiety disorders
were in accordance with findings in our previous inter-
view study and with actual recommendations[12,25,26].
Psychotherapy was considered most often as a comple-
ment to drugs in the treatment of depression. In the pre-
vious interview study, the majority of the interviewees
presented a positive attitude to psychotherapy[12]. There
is now good evidence for the effectiveness of several forms
of psychotherapy against moderate depressions [27-34].
These findings appear not to have become generally
accepted by Swedish GPs, probably partly due to the lim-
ited access to psychotherapists.
A clear majority of the GPs in the present study perceived
the work with depressed patients in a predominantly pos-
itive way. A notable finding was the great importance they
Use of antidepressive agents in other conditions than depressionFigure 3
Use of antidepressive agents in other conditions than depression. Antidepressive agents can be used in other condi-
tions than depression. Give for each statement your degree of agreement: a. ADs are effective in panic disorder. b. ADs are 
effective in obsessive-compulsive disorder. c. ADs are effective in social phobia. d. ADs are effective against insomnia.
0 20 40 60 80 100
Antidepressive agents are
effective in panic disorder
Antidepressive agents are effective in
obsessive compulsive disorder
Antidepressive agents are 
effective in social phobia
Antidepressive agents are 
effective against insomnia
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and from private life. That was valid for both treatment
decisions and for their manner of working, and the same
came out in the interview study[13]. Judging from these
responses, GPs try to consider treatment guidelines as well
as patients' attitudes to treatment and their individual
experiences of similar situations when they propose treat-
ments. In such complex decision situations, the physi-
cians seem to perceive their individual experiences as
indispensable. That is in accordance with Schön, who
reported that practitioners gather repertoires of under-
standings and actions from their experiences, and that
they use their repertoires to guide their professional
actions. The quality of this guidance varies. A practitioner
must have worked through his/her experiences by discus-
Depressive disorders in old peopleFigure 4
Depressive disorders in old people. Here follow some statements on depressive disorders and their treatment in old peo-
ple. Mark for each statement which degree of agreement you have: a. Depressive disorders in old people have more of biolog-
ical causes then depressive disorders in younger ages. b. ADs are as effective in old people as in middle age people. c. 
Psychotherapy is as effective in old people as in middle age persons. d. ADs are effective against anxiety and behaviour disorder 
in people with dementia.
0 20 40 60 80 100
Depressive disorders in old people 
have more of biological causes than 
depressive disorders at younger ages
Antidepressive agents are as effective
in old people as in middle age persons
Psychotherapy is as effective in old 
people as in middle age persons
Antidepressive agents are effective
against anxiety and behavior
disorders in people with dementia
Percent of respondents
Agree not at all
Agree partly
Agree completely
Table 1: Factors that may have influenced on GPs' manner of 
working with depressed patients. Share of respondents that have 
marked "great" or "very great" importance on the factor in 
question.
Experiences from general practice 96 %
Experiences from private life 83 %
Residency in psychiatry 57 %
Professional reading 50 %
Education on communication 50 %
A mentor colleague 26 %
Reading fiction literature 20 %
Religious faith 17 %
University education 12 %
Popular reading on psychiatry/psychology 10 %Page 6 of 9
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valuable guide[35].
To a substantial degree, the outcome in drug treatment of
depression is dependent on the therapeutic alliance
between the physician and the patient[36]. This alliance is
built up by the physician's ability to communicate, which
is acquired mainly through individual experience, guiding
and reflective reading.
When professionals rely primarily on personal experi-
ences as grounds for clinical assessment and intervention,
they demonstrate preference for "knowledge in action"
over inquiring scientific knowledge, and, tentatively, a
scepticism regarding the usefulness of scientific litera-
ture[37]. Many respondents' low or moderate evaluation
of their undergraduate education indicates such scepti-
cism. Lennarson Greer writes about "the problem of
uncertainty" as a key problem of the medical profes-
sion[38]. For many physicians, trust in personal experi-
Table 2: Respondents' reports of occasions of participation in education/lectures each year. Number of respondents.
Not regularly 1 – 3 /year 4 – 7/year >7/year
Arrangements without industry involvement 74 127 71 43
Arranged by pharmaceutical industries 30 141 81 62
Pharmaceutical companies' information and courses on depressionFigure 5
Pharmaceutical companies' information and courses on depression. Here follow five statements about the pharma-
ceutical companies' information and courses on depression and antidepressive agents. Mark for each statement your degree of 
agreement: a. The company representants' information on antidepressive agents keeps high standards. b. Their courses on 
depression and depression treatment keep high standards. c. Their information and education on treatment of depression have 
given me more knowledge than commercially independent education. d. The pharmaceutical companies' information  and edu-
cation pose a risk of non-appropriate influence in the selection of treatment.
The company representants’ information on 
antidepressive agents keeps high standard
0 20 40 60 80 100
Their courses on depression and 
depression treatment keep high
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Their information and education on treatment of 
depression have given me more knowledge than 
commercially independent education
The pharmaceutical companies’ information
and education pose a risk of non-appropriate
influence in selection of treatment
Percent of respondents
Agree not at all
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handle the worry of uncertainty than reading scientific
literature[38,39].
Thus, the respondents' emphasis on their own experiences
is understandable, but, on the other side, a low evaluation
of scientific and evidence-based knowledge may imply
insufficient capability to form an accurate opinion of a
patient's state and to propose an optimal treatment.
Even if the respondents ranked their own experiences of
clinical work and private life as most important, they also
indicated that lectures and professional reading are
important sources of knowledge about depression. Fur-
ther, the striking increase of prescriptions of ADs in the
1990s indicates that recognition and management of
depressive disorders have changed[40,41]. Reasonably,
that is due to other influences than GPs' own experience.
Psychiatric specialists have probably had an impact on
GPs' prescribing, partly directly by initiating or recom-
mending treatment for patients, partly indirectly by edu-
cation and informal consultations. The pharmaceutical
companies' marketing of ADs is another powerful incen-
tive to increase the use of ADs. In our previous study we
learned that high sales levels correlated with more partic-
ipation in the pharmaceutical companies' activities[14].
Also other studies have documented the impact of com-
mercial marketing on prescribing and professional behav-
iour of physicians [42-45].
GPs stand out as a cultural subgroup, where ongoing edu-
cational, collegial and marketing influences are obvious
from outside but not quite clear for the members them-
selves. Many GPs appear to overlook these external influ-
ences on their thinking and professional behaviour, while
they tend to over-emphasize individual experiences as a
base of their clinical work.
To some extent, GPs' disappointment with psychiatric
services may depend on unrealistic ideas about psychia-
trists' ability to solve GPs' problems. It has been pointed
out that GPs and psychiatrists have different
preconditions in their clinical work, and that they meet
different kinds of depressed patients[3,46]. Projects to
improve depression management have reported that sim-
ple guideline implementation and educational strategies
were generally ineffective. In short term evaluation, effec-
tive strategies were those with broad interventions that
incorporated clinical education, enhanced team work and
a greater integration between primary care and psychiatry
[46-50].
Conclusion
In their conceptions of factors that form their way to treat
depressed patients, GPs tend to emphasize experiences,
both from clinical work and private life, and overlook
influences of collegial dealings and ongoing CME as well
as the effects of the pharmaceutical companies' marketing
activities. Many GPs appear to need more evidence based
knowledge about depressive disorders. Interventions to
improve depression management have to be supporting
and interactive and combined with organisational
reforms to improve co-operation with psychiatrists.
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